Cipla Q2 PAT up 11% PAT to Rs 789 cr on strong Covid-adjusted growth rate

The company is de-risking key product Abraxane in case the Goa plant FDA issue is not cleared immediately

Mumbai-headquartered Cipla has posted an 11 per cent year-on-year (YoY) rise in profit after tax for the second quarter of the current fiscal to Rs 789 crore as its total revenue from operations grew 5.6 per cent to Rs 5,829 crore.

Revenue growth for the quarter was at 6 per cent on a reported basis and a strong 12 per cent on a Covid-adjusted base of last year. “There were no Covid-19 sales this quarter. If we adjust for that, then we have a 12 per cent growth at a company level, and a 15 per cent growth in India,”